Who can order GPS Cancer?
GPS Cancer must be ordered by a physician.
What samples are required for testing?
Patients must provide a tumor sample and a blood sample—both of which are needed for the accurate identification of tumor genome sequencing.
How is GPS Cancer profiling different from other tumor genomic testing?
By pairing DNA sequencing with RNA sequencing, GPS Cancer analyzes more of the genetic material located in tumors than many other available tests. It also compares tumor tissue with normal healthy cells to differentiate between benign alterations and those that may drive cancer. This comprehensive approach equips oncologists with molecular insights that can inform targeted cancer therapies. For supporting research, consult our Clinical Evidence page.
Where does GPS Cancer profiling occur?
All GPS Cancer sequencing is performed in CAP-accredited, CLIA-certified labs.
How long does it take to receive the GPS Cancer profile results?
Results are typically available within 21 days from the receipt of samples and completed paperwork.
What is GPS Cancer?
GPS Cancer is a molecular test that can identify alterations in the DNA and RNA of a person’s tumor sample. This comprehensive profile equips oncologists with personalized insights that may inform targeted treatment options based on the unique characteristics of your cancer.
Am I eligible for GPS Cancer?
You should talk with your physician whether GPS Cancer is appropriate for your type of cancer.
What samples are collected for testing?
Your doctor will collect tissue and blood samples, and then send them to the GPS Cancer lab for testing.
How do I review my results?
After analyzing the DNA and RNA in your tumor, we send the results to your doctor within approximately 21 days. Your doctor will review your GPS Cancer results with you and discuss potential treatment options.